Showing results (1-10 of 9) with videos related to
Sort By:
Pageof 1
Frontiers in Pharmacology|May 9, 2025
Corrigendum: Mechanism of Valeriana officinalis L. extract improving atherosclerosis by regulating PGC-1α/Sirt3/Epac1 pathwayBo Yao, Jingzhuo Ma, Qingzhi Ran, et al.Frontiers in Pharmacology|December 4, 2024
Mechanism of Valeriana officinalis L. extract improving atherosclerosis by regulating PGC-1α/Sirt3/Epac1 pathwayBo Yao, Jingzhuo Ma, Qingzhi Ran, et al.Pharmacological Research|June 29, 2024
Action and therapeutic targets of myosin light chain kinase, an important cardiovascular signaling mechanismQingzhi Ran, Aoshuang Li, Yuqing Tan, et al.Frontiers in Cell and Developmental Biology|October 1, 2025
Mitochondrial fission process 1 protein: a comprehensive review of its core roles in mitochondrial dynamics, disease, and therapeutic targetsQingzhi Ran, Chen Gao, Chunrong Xiang, et al.Frontiers in Cardiovascular Medicine|April 1, 2024
Mendelian randomization of chronic hepatitis B and cardiovascular diseaseDongjie Wu, Feiyang Xiong, Qingzhi Ran, et al.Frontiers in Cardiovascular Medicine|January 26, 2026
Murine hindlimb ischemia models: a narrative reviewYongkang Zhang, Hongcheng Du, Qingzhi Ran, et al.Frontiers in Cell and Developmental Biology|March 27, 2025
Action and therapeutic targets of folliculin interacting protein 1: a novel signaling mechanism in redox regulationQingzhi Ran, Aoshuang Li, Bo Yao, et al.Sports Medicine and Health Science|September 5, 2024
Effects of COVID-19 on the cardiovascular system: A mendelian randomization studyQingzhi Ran, Aoshuang Li, Rui Li, et al.Thrombosis Research|February 22, 2024
The effects of CYP2C19 genotype polymorphism and clopidogrel resistance on ischemic event occurrence in patients with peripheral arterial disease undergoing revascularization: A prospective cohort studyYongkang Zhang, Qingzhi Ran, Kangli Yin, et al.Pageof 1